| scholarly article | Q13442814 |
| P356 | DOI | 10.1254/JJP.60.91 |
| P953 | full work available at URL | https://www.jstage.jst.go.jp/article/jphs1951/60/2/60_2_91/_pdf |
| P698 | PubMed publication ID | 1282576 |
| P2093 | author name string | N. Arai | |
| S. Kikuchi | |||
| A. Koda | |||
| H. Suzawa | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 91-96 | |
| P577 | publication date | 1992-10-01 | |
| P1433 | published in | The Japanese Journal of Pharmacology | Q45115274 |
| P1476 | title | The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts | |
| P478 | volume | 60 |
| Q77585444 | Angiogenesis in pathological and surgical scars |
| Q45217870 | Antagonistic effects of tranilast on proliferation and collagen synthesis induced by TGF-beta2 in cultured human trabecular meshwork cells |
| Q42178648 | Antiproliferative and c-myc mRNA suppressive effect of tranilast on newborn human vascular smooth muscle cells in culture |
| Q55709554 | Assessing the response of morphea and limited scleroderma to tranilast: a small prospective study comparing topical corticosteroids to a combination of topical corticosteroids and tranilast. |
| Q36627103 | Attenuation of amiodarone induced lung fibrosis and phospholipidosis in hamsters, by treatment with the platelet activating factor receptor antagonist, WEB 2086 |
| Q35439417 | Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine |
| Q64057927 | Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System |
| Q92728117 | Cardiac fibrosis: potential therapeutic targets |
| Q73219513 | Effect of Tranilast on chronic graft vascular disease and tracheal proliferation in a rat allograft model |
| Q41137969 | Effect of azelastine on PGE2 production in fibroblasts in normal skin. The possibility of inhibition of inducible cyclooxygenase by azelastine |
| Q36139952 | Effective treatment for prevention of post-operative adhesion after strabismus surgery in experimental rabbit model: 0.5 % tranilast ophthalmic solution |
| Q73833368 | Effectiveness of tranilast on restenosis after directional coronary atherectomy |
| Q44346218 | Effects of fibroblast growth inhibitor on proliferation and metastasis of oral squamous cell carcinoma |
| Q90282198 | Effects of tranilast on the epithelial-to-mesenchymal transition in peritoneal mesothelial cells |
| Q46406257 | Expression, localisation and function of ACE and chymase in normal and atherosclerotic human coronary arteries |
| Q40848340 | Hepatic fibrosis--current concepts of pathogenesis and therapy |
| Q57162899 | Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition |
| Q73128372 | Impact of tranilast on restenosis after coronary angioplasty: tranilast restenosis following angioplasty trial (TREAT) |
| Q47101405 | Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast |
| Q32110855 | Inflammatory endobronchial stenosis |
| Q47712082 | Inhibition by tranilast of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF)-induced increase in vascular permeability in rats |
| Q73662537 | Inhibition of neointima formation by tranilast in pig coronary arteries after balloon angioplasty and stent implantation |
| Q73205042 | Inhibitory influences of tranilast on multinucleated giant cell formation from monocytes by supernatant of concanavalin A-stimulated mononuclear cells |
| Q41813563 | Innovative therapies in the treatment of keloids and hypertrophic scars |
| Q89687959 | Keloid pathophysiology: fibroblast or inflammatory disorders? |
| Q41882581 | Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance |
| Q34633683 | Kynurenine pathway metabolites in humans: disease and healthy States |
| Q77522059 | Medical therapies for the prevention of restenosis after percutaneous coronary interventions |
| Q34021948 | Nonsteroidal Anti-Inflammatory Drugs for Wounds: Pain Relief or Excessive Scar Formation? |
| Q41953103 | Overexpression of RACK1 inhibits collagen synthesis in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway |
| Q36921222 | Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations |
| Q34265668 | Placement of self-expandable metallic stents for tracheal stenosis secondary to thyroid cancer |
| Q77644012 | Preventive effects of an antiallergic drug, pemirolast potassium, on restenosis after percutaneous transluminal coronary angioplasty |
| Q57483726 | Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor |
| Q41944864 | Response of keloid fibroblasts to Vitamin D3 and quercetin treatment - in vitro study |
| Q38649653 | Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions |
| Q34393387 | Successful treatment of desmoid tumor of the chest wall with tranilast: a case report |
| Q73585262 | Suppressive effects of tranilast on the expression of inducible cyclooxygenase (COX2) in interleukin-1beta-stimulated fibroblasts |
| Q44126549 | Synthesis and structure-activity relationship of diarylamide derivatives as selective inhibitors of the proliferation of human endothelial cells |
| Q26863340 | Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy |
| Q50159459 | Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors |
| Q96304791 | The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models |
| Q39253354 | The anti-allergic compound tranilast attenuates inflammation and inhibits bone destruction in collagen-induced arthritis in mice |
| Q77739050 | The effect of the anti-allergic agent avil on abnormal scar fibroblasts |
| Q77958177 | The prevention of postoperative intraperitoneal adhesions by tranilast: N-(3',4'-dimethoxycinnamoyl)anthranilic acid |
| Q57281933 | Therapeutic potential of tranilast for the treatment of chronic graft-versus-host disease in mice |
| Q46470767 | Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice |
| Q46983859 | Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells |
| Q60472198 | Tranilast attenuates vascular hypertrophy, matrix accumulation and growth factor overexpression in experimental diabetes |
| Q37284410 | Tranilast enhances the anti-tumor effects of tamoxifen on human breast cancer cells in vitro. |
| Q64944714 | Tranilast enhances the effect of anticancer agents in osteosarcoma. |
| Q73501161 | Tranilast inhibits contraction of rat aortic smooth muscle |
| Q35028866 | Tranilast inhibits protein kinase C-dependent signalling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells |
| Q52718681 | Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cells. |
| Q43178739 | Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo |
| Q73031635 | Tranilast suppresses the vascular intimal hyperplasia after balloon injury in rabbits fed on a high-cholesterol diet |
| Q77725736 | Tranilast, an anti-allergic drug, possesses antagonistic potency to angiotensin II |
| Q37743995 | Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner. |
Search more.